1414 Antitumor effect of HER2-hICD vaccine combining with HER2 ADC depending on T cell existence in a mouse model: pooled analysis

• Hye-Ran Kim,
• Eunkyo Joung,
• Jinback Lim,
• Hyo-Hyun Park,
• Hun Jung,
• Jinho Kang,
• Chul-Woong Chung,
• Soyeon Lim,
• Yun-Hee Park,
• Jin Kyeong Choi,
• Jee Hyun Choi,
• Seong-Yong Jang,
• Min-Ah Kim,
• Myeong-Kyu Park

Affiliations

Hye-Ran Kim

2Gwangju Institute of Science and Technology, Gwangju, Republic of Korea

Eunkyo Joung

1Aston Sci. Inc., Seoul, Republic of Korea

Jinback Lim

1Aston Sci. Inc., Seoul, Republic of Korea

Hyo-Hyun Park

1Aston Sci. Inc., Seoul, Republic of Korea

Hun Jung

1Aston Sci. Inc., Seoul, Republic of Korea

Jinho Kang

1Aston Sci. Inc., Seoul, Republic of Korea

Chul-Woong Chung

4LegoChem Biosciences, Inc., Daejeon, Republic of Korea

Soyeon Lim

4LegoChem Biosciences, Inc., Daejeon, Republic of Korea

Yun-Hee Park

4LegoChem Biosciences, Inc., Daejeon, Republic of Korea

Jin Kyeong Choi

5Jeonbuk National University Medical School, Jeonju, Republic of Korea

Jee Hyun Choi

1Aston Sci. Inc., Seoul, Republic of Korea

Seong-Yong Jang

3Korea Testing and Research Institute, Hwasun, Republic of Korea

Min-Ah Kim

3Korea Testing and Research Institute, Hwasun, Republic of Korea

Myeong-Kyu Park

3Korea Testing and Research Institute, Hwasun, Republic of Korea